162 related articles for article (PubMed ID: 15533803)
1. Factors predicting an increased dose to the penile bulb in permanent seed prostate brachytherapy.
Taussky D; Haider M; McLean M; Yeung I; Williams T; Pearson S; Lockwood G; Crook J
Brachytherapy; 2004; 3(3):125-9. PubMed ID: 15533803
[TBL] [Abstract][Full Text] [Related]
2. Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk.
Crook JM; Potters L; Stock RG; Zelefsky MJ
Brachytherapy; 2005; 4(3):186-94. PubMed ID: 16182218
[TBL] [Abstract][Full Text] [Related]
3. Novel prostate brachytherapy technique: improved dosimetric and clinical outcome.
Nobes JP; Khaksar SJ; Hawkins MA; Cunningham MJ; Langley SE; Laing RW
Radiother Oncol; 2008 Jul; 88(1):121-6. PubMed ID: 18499289
[TBL] [Abstract][Full Text] [Related]
4. The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy.
Buyyounouski MK; Horwitz EM; Uzzo RG; Price RA; McNeeley SW; Azizi D; Hanlon AL; Milestone BN; Pollack A
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1383-91. PubMed ID: 15275723
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: is dose to the penile bulb important?
Macdonald AG; Keyes M; Kruk A; Duncan G; Moravan V; Morris WJ
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):155-63. PubMed ID: 16111584
[TBL] [Abstract][Full Text] [Related]
6. Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review.
van der Wielen GJ; Mulhall JP; Incrocci L
Radiother Oncol; 2007 Aug; 84(2):107-13. PubMed ID: 17707936
[TBL] [Abstract][Full Text] [Related]
7. There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.
Solan AN; Cesaretti JA; Stone NN; Stock RG
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1468-74. PubMed ID: 18922652
[TBL] [Abstract][Full Text] [Related]
8. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
9. Radiation dose to the internal pudendal arteries from permanent-seed prostate brachytherapy as determined by time-of-flight MR angiography.
Gillan C; Kirilova A; Landon A; Yeung I; Pond G; Crook J
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):688-93. PubMed ID: 16626892
[TBL] [Abstract][Full Text] [Related]
10. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
Pickett B; Pouliot J
Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
[TBL] [Abstract][Full Text] [Related]
11. MRI-based preplanning in low-dose-rate prostate brachytherapy.
Tanaka O; Hayashi S; Matsuo M; Nakano M; Kubota Y; Maeda S; Ohtakara K; Deguchi T; Hoshi H
Radiother Oncol; 2008 Jul; 88(1):115-20. PubMed ID: 17933407
[TBL] [Abstract][Full Text] [Related]
12. Erectile dysfunction and radiation dose to penile base structures: a lack of correlation.
Selek U; Cheung R; Lii M; Allen P; Steadham RE; Vantreese TR; Little DJ; Rosen II; Kuban D
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1039-46. PubMed ID: 15234037
[TBL] [Abstract][Full Text] [Related]
13. Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy?
Potters L; Calugaru E; Jassal A; Presser J
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1014-9. PubMed ID: 16682144
[TBL] [Abstract][Full Text] [Related]
14. Dose-volume parameters of the corpora cavernosa do not correlate with erectile dysfunction after external beam radiotherapy for prostate cancer: results from a dose-escalation trial.
van der Wielen GJ; Hoogeman MS; Dohle GR; van Putten WL; Incrocci L
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):795-800. PubMed ID: 18164862
[TBL] [Abstract][Full Text] [Related]
15. Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer.
Wernicke AG; Valicenti R; Dieva K; Houser C; Pequignot E
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1357-63. PubMed ID: 15590165
[TBL] [Abstract][Full Text] [Related]
16. The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction.
Merrick GS; Butler WM; Wallner KE; Lief JH; Anderson RL; Smeiles BJ; Galbreath RW; Benson ML
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(4):1055-62. PubMed ID: 12419431
[TBL] [Abstract][Full Text] [Related]
17. Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy.
Wust P; von Borczyskowski DW; Henkel T; Rosner C; Graf R; Tilly W; Budach V; Felix R; Kahmann F
Radiother Oncol; 2004 Oct; 73(1):39-48. PubMed ID: 15465144
[TBL] [Abstract][Full Text] [Related]
18. Erectile function durability following permanent prostate brachytherapy.
Taira AV; Merrick GS; Galbreath RW; Butler WM; Wallner KE; Kurko BS; Anderson R; Lief JH
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):639-48. PubMed ID: 19303721
[TBL] [Abstract][Full Text] [Related]
19. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications.
Zelefsky MJ; Yamada Y; Cohen GN; Sharma N; Shippy AM; Fridman D; Zaider M
Radiother Oncol; 2007 Aug; 84(2):185-9. PubMed ID: 17692978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]